Neil H. James

2.8k citations

28 papers · 1.5k indexed · h-index 22

Cancer Research top 10%
Oncology top 5%
- Drug Transport and Resistance Mechanisms 5
Molecular Biology top 10%
- Peroxisome Proliferator-Activated Receptors 14
- PI3K/AKT/mTOR signaling in cancer 6
- Angiogenesis and VEGF in Cancer 4
- Metabolism, Diabetes, and Cancer 4
Hepatology top 10%
Pharmacology top 5%
- Drug-Induced Hepatotoxicity and Protection 4
Epidemiology
- Liver Disease Diagnosis and Treatment 4
Physiology
- Adipose Tissue and Metabolism 4

Co-authors: Ruth Roberts Susan C. Hasmall Sabina Cosulich Neil Macdonald Anthony R. Soames Peter R. Holden Eric B. Wheeldon Jason H. Gill
Cited by: Cancer Research Oncology Molecular Biology
Partner nations: United Kingdom United States Japan

In The Last Decade

Neil H. James

27 papers receiving 1.4k citations

Peers

Countries citing papers authored by Neil H. James

Since Specialization

Citations

This map shows the geographic impact of Neil H. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil H. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil H. James more than expected).

Fields of papers citing papers by Neil H. James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil H. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil H. James. The network helps show where Neil H. James may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Neil H. James, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Neil H. James Line = papers co-authored together Neil H. James links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control Kyoko Nakamura,Ankur Karmokar,Paul Farrington,Neil H. James,Antonio Ramos‐Montoya,Susan J. Bickerton,Gareth Hughes,Tim Illidge,Elaine Cadogan,Barry R. Davies,Simon J. Dovedi,Viia Valge-Archer	2021	43
2	Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells Rebecca L. Lloyd,Paul W.G. Wijnhoven,Antonio Ramos‐Montoya,Zena Wilson,Giuditta Illuzzi,Katarzyna Falenta,Gemma N. Jones,Neil H. James,Christophe D. Chabbert,Jonathan Stott,Emma Dean,Alan Lau,Lucy A. Young	2020	126
3	Tumors with AKT1E17K Mutations Are Rational Targets for Single Agent or Combination Therapy with AKT Inhibitors Barry R. Davies,Nin Guan,Armelle Logié,Claire Crafter,Lyndsey Hanson,Vivien N. Jacobs,Neil H. James,Philippa Dudley,Kelly Jacques,Brendon Ladd,Celina M. D’Cruz,Michael Zinda,Justin P.O. Lindemann,Makoto Kodaira,Kenji Tamura,Emma Jenkins	2015	54
4	Combining AZD8931, a novel EGFR/HER2/HER3 signalling inhibitor, with AZD5363 limits AKT inhibitor induced feedback and enhances antitumour efficacy in HER2-amplified breast cancer models Claire Crafter,John P. Vincent,Eric Tang,Phillippa Dudley,Neil H. James,Teresa Klinowska,Barry R. Davies	2015	31
5	Assessing the Activity of Cediranib, a VEGFR-2/3 Tyrosine Kinase Inhibitor, against VEGFR-1 and Members of the Structurally Related PDGFR Family Sandra R. Brave,Kirsty Ratcliffe,Zena Wilson,Neil H. James,Sue Ashton,Anna Wainwright,Jane Kendrew,Philippa Dudley,Nicola Broadbent,Graham Sproat,Sian Taylor,Claire H. Barnes,Jeffrey C. Silva,Charles L. Farnsworth,Laurent Hennequin,Donald Ogilvie,Juliane M. Jürgensmeier,Masabumi Shibuya,Stephen R. Wedge,Simon T. Barry	2011	72
6	Vascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers Neil R. Smith,Dawn Baker,Neil H. James,Kirsty Ratcliffe,Martin Jenkins,Susan Ashton,Graham Sproat,Ruth Swann,Neil Gray,Anderson J. Ryan,Juliane M. Jürgensmeier,Chris Womack	2010	197
7	Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus Stephen B. Fox,Helen Turley,Michelle Cheale,Cristina Blázquez,Helen Roberts,Neil H. James,Nathan P. Cook,Adrian L. Harris,Kevin C. Gatter	2004	45
8	Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect? Ruth Roberts,Neil H. James,Sabina Cosulich,Susan C. Hasmall,George M. Orphanides	2001	16
9	Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor α (PPARα) Susan C. Hasmall,Neil H. James,Kathryn Hedley,Kine Olsen,Ruth Roberts	2001	20
10	Identification of a possible association between carbon tetrachloride-induced hepatotoxicity and interleukin-8 expression Peter R. Holden,Neil H. James,A. Nigel Brooks,Ruth Roberts,Ian Kimber,William D. Pennie	2000	29
11	Apoptosis and proliferation in nongenotoxic carcinogenesis: species differences and role of PPARα Ruth Roberts,Neil H. James,Susan C. Hasmall,Peter R. Holden,Kevin G. Lambe,Neil Macdonald,Douglas A. West,N.J Woodyatt,D Whitcome	2000	56
12	Suppression of mouse hepatocyte apoptosis by peroxisome proliferators: role of PPARα and TNFα Susan C. Hasmall,Neil H. James,Neil Macdonald,Frank J. Gonzalez,Jeffrey M. Peters,Ruth Roberts	2000	45
13	Species differences in response to diethylhexylphthalate: suppression of apoptosis, induction of DNA synthesis and peroxisome proliferator activated receptor alpha-mediated gene expression Susan C. Hasmall,Neil H. James,Neil Macdonald,Anthony R. Soames,Ruth Roberts	2000	62
14	Suppression of apoptosis and induction of DNA synthesis in vitro by the phthalate plasticizers monoethylhexylphthalate (MEHP) and diisononylphthalate (DINP): a comparison of rat and human hepatocytes in vitro Susan C. Hasmall,Neil H. James,Neil Macdonald,Douglas A. West,Stéphan Chevalier,Sabina Cosulich,Ruth A. Roberts	1999	31
15	Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis Neil H. James,Jason H. Gill,Richard Brindle,N.J Woodyatt,Neil Macdonald,Mark W. Rolfe,Susan C. Hasmall,Jonathan Tugwood,Peter R. Holden,Ruth Roberts	1998	23
16	A peroxisome proliferator-activated receptor-alpha (PPARα) cDNA cloned from guinea-pig liver encodes a protein with similar properties to the mouse PPARα: implications for species differences in responses to peroxisome proliferators Jonathan Tugwood,Peter R. Holden,Neil H. James,Rebecca A. Prince,Ruth Roberts	1998	76
17	Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis Neil H. James,Ruth Roberts	1996	87
18	Non-genotoxic hepatocarcinogenesis stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations Ruth Roberts,Anthony R. Soames,Jason H. Gill,Neil H. James,Eric B. Wheeldon	1995	88
19	Dosing-Induced Stress Causes Hepatocyte Apoptosis in Rats Primed by the Rodent Nongenotoxic Hepatocarcinogen Cyproterone Acetate Ruth Roberts,Anthony R. Soames,Neil H. James,Jason H. Gill,Eric B. Wheeldon	1995	30
20	An in vitro model of rodent nongenotoxic hepatocarcinogenesis Neil H. James,Catherine A. Molloy,Anthony R. Soames,Nicola J. French,Ruth Roberts	1992	8

About Neil H. James

Neil H. James is a scholar working on Cancer Research, Pharmacology and Oncology, having authored 28 papers that have together received 1.5k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (14 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Drug Transport and Resistance Mechanisms (5 papers), Liver Disease Diagnosis and Treatment (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Adipose Tissue and Metabolism (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Cancer Research (303 citations), Oncology (545 citations) and Molecular Biology (1.0k citations). Neil H. James has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Ruth Roberts, Susan C. Hasmall, Sabina Cosulich, Neil Macdonald, Anthony R. Soames, Peter R. Holden, Eric B. Wheeldon, Jason H. Gill, Juliane M. Jürgensmeier and Neil R. Smith.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact